Related Experiment Video
Updated: Aug 15, 2026

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
Published on: December 6, 2014
Molecular defects in T- and B-cell primary immunodeficiency diseases
Charlotte Cunningham-Rundles1, Prashant P Ponda
1Division of Clinical Immunology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1089, New York, New York 10029, USA. charlotte.cunningham-rundles@mssm.edu
Over 120 inherited primary immunodeficiency diseases are known, with genetic defects increasingly identified. Advances in diagnosis and therapy offer better outcomes, with gene therapy showing promise for these conditions.
Area of Science:
- Immunology and Genetics
- Molecular Medicine
Background:
- Over 120 inherited primary immunodeficiency diseases (IPIDs) have been identified over the last 50 years.
- The specific genetic defects underlying many IPIDs are now understood.
- Understanding these molecular defects impacts basic and translational research across medicine.
Purpose of the Study:
- To review the advancements in understanding and managing inherited primary immunodeficiency diseases.
- To highlight the influence of molecular defect identification on medical research and practice.
- To discuss the evolving diagnostic and therapeutic landscape, including the potential of gene therapy.
Main Methods:
- Review of scientific literature and clinical findings related to inherited primary immunodeficiency diseases.
- Analysis of the impact of genetic defect identification on research and clinical outcomes.
- Assessment of current and future therapeutic strategies, including gene therapy.
Main Results:
- Significant progress has been made in identifying the genetic causes of numerous IPIDs.
- Enhanced understanding of molecular defects has driven innovation in basic and translational research.
- Advances in diagnostics and therapeutics lead to earlier detection and improved long-term patient outcomes.
Conclusions:
- The identification of genetic defects in IPIDs has revolutionized their study and management.
- Current diagnostic and therapeutic modalities offer more precise and effective treatments.
- Gene therapy represents a promising future treatment avenue for individuals with IPIDs.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

